[Clinical significance of Lewis blood-group phenotype and serum CA-19-9 analysis in the diagnosis of diabetic diseases].
Shimojo
N
N
Department of Laboratory Medicine, Osaka City University Medical School.
Okuda
K
K
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis*; D003930:Diabetic Retinopathy / Q000097:blood / Q000175:diagnosis; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007983:Lewis Blood Group Antigens / Q000276:immunology*; D008297:Male; D011863:Radioimmunoassay
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D001786:Blood Glucose; D007983:Lewis Blood Group Antigens